SE192426C1 - - Google Patents

Info

Publication number
SE192426C1
SE192426C1 SE192426DA SE192426C1 SE 192426 C1 SE192426 C1 SE 192426C1 SE 192426D A SE192426D A SE 192426DA SE 192426 C1 SE192426 C1 SE 192426C1
Authority
SE
Sweden
Prior art keywords
cephalosporin
solution
antibiotic
kit according
acid
Prior art date
Application number
Other languages
Swedish (sv)
Publication date
Publication of SE192426C1 publication Critical patent/SE192426C1/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P35/00Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
    • C12P35/06Cephalosporin C; Derivatives thereof

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cephalosporin Compounds (AREA)

Description

Uppfinnare: E P Abraham och G G F Newton Prioritet begard frau den 2 f ebruari och 16 junt 1955 (Storbritannien) Det har redan pavisats, att ett naringssubstrat, om det fOrjases med mOgel av den art, av vilken Cephalosporium I. M. I. 49 137 (American Type Culture Collection No. 11 550) Or en medlem, far antibiotisk aktivitet. Isoleringen av Lva olika antibiotika ur medlet har redan beskrivits i detalj. Det ena av dessa antibiotika är huvudsakligen verksamt mot grampositiva bakterier och Or kOnt sorn cephalosporin P. Det andra antibiotikumet, vilket Or kant som cephalosporin N, utgOr ett penicillinas-kansligt material, som Or verksamt mot bhde gramnegativa och grampositiva bakterier. Inventors: EP Abraham and GGF Newton Priority requested from 2 February and 16 June 1955 (UK) It has already been shown that a nutrient medium, if contaminated with mold of the species of which Cephalosporium IMI 49 137 (American Type Culture Collection No. 11 550) Or a member, father antibiotic activity. The isolation of Lva various antibiotics from the agent has already been described in detail. One of these antibiotics is mainly effective against gram-positive bacteria and cephalosporin P.

I den brittiska patentskriften 745 208 beskrives ett jasningsforfarande for framstallning av cephalosporin N och olika forfaranden for ea:allande av cephalosporin N i ren form. British Patent Specification 745,208 discloses a fermentation process for the preparation of cephalosporin N and various processes for the preparation of cephalosporin N in pure form.

Foreliggande uppfinning grundar sig ph den iakttagelsen, att ndr cephalosporin N i rapreparat av ndmnda Mune OverfOres i en inaktiv forming, hdr bendmnd cephalosporin N penillinsyra, genom att preparatet Mlles en viss tid vid surt pH, exempelvis 2,5-5,5, kommer preparatet trots detta att uppvisa antibiotisk aktivitet ph grund av ndrvaron av en Latins okand substans. Detta tredje antibiotiska material, vilket nu betecknas cephalosporin C, Or liksom cephalosporin N aktivt mot bade grampositiva och gramnegativa bakterier men i motsats till cephalosporin N okdnsligt mot penicillinas framstalld av B. subtilis. Det nya materialet Or losligt i vatten och ndstan olosligt i etanol och eter. Det kan identifieras genom sitt ultravioletta absorptionsspektrum, vilket, da. antibiotikumet foreligger i form av en vattenlosning av dess natriumsalt med en specifik vridning av [a]r + 103°, har ett ultraviolett absorptionsmaximum vid 260 miz. The present invention is based on the observation that if the cephalosporin N in the preparation of the said Mune OverfOres is in an inactive form, the cephalosporin N penicillin acid the preparation nevertheless to exhibit antibiotic activity ph due to the presence of a Latin unknown substance. This third antibiotic material, now called cephalosporin C, Or as well as cephalosporin N is active against both gram-positive and gram-negative bacteria but in contrast to cephalosporin N is insensitive to penicillinase produced by B. subtilis. The new material is soluble in water and almost insoluble in ethanol and ether. It can be identified by its ultraviolet absorption spectrum, which, da. the antibiotic is in the form of an aqueous solution of its sodium salt with a specific rotation of [a] r + 103 °, has an ultraviolet absorption maximum at 260 miz.

Genom foreliggande uppfinning erhalles sAlunda Dupl. kl. 30 h: 2/03 ett antibiotikum, vilket i fortsdttningen bendmnes cephalosporin C samt kan erhallas i blandning med cephalosporin N penillinsyra, om ett rapreparat av cephalosporin N halles vid sadant pII-varde, att cephalosporin N omsdttes till cephalosporin-N-penillinsyra. Detta antiobiotikum, cephalosporin C, besitter aktivitet mot bAde grampositiva och gramnegativa bakterier, är stabilt vid pH 2,5-5, Or lOsligt i vatten och ndstan olOsligt i etanol och eter. Det uppvisar vidare, dd. det foreligger i form av en vattenlOsning av natriumsaltet, cii specifik vridningsformaga av [a] g + 103° och ett ultraviolett absorptions-. maximum vid 260 mitt. By the present invention sAlunda Dupl. at 30 h: 2/03 an antibiotic, which in turn is cephalosporin C and can be obtained in admixture with cephalosporin N penillic acid, if a preparation of cephalosporin N is taken at such a pII value that cephalosporin N is converted to cephalosporin N-penillinic acid. This antibiotic, cephalosporin C, has activity against both gram-positive and gram-negative bacteria, is stable at pH 2.5-5, soluble in water and almost insoluble in ethanol and ether. It shows further, dd. it is in the form of an aqueous solution of the sodium salt, cii specific torsional shape of [a] g + 103 ° and an ultraviolet absorption. maximum at 260 mid.

Ovan namnda brittiska patentskrift 745 208 omfattar bl. a. ett forfarande for rening av cephalosporin N genom separering av mycelium frau mdsken, efterfoljande adsorbtion av cephalosporin N ur den klara vdtskan ph aktivt kol och darph foljande elnering den antibiotiska substansen frau adsorbtionsmedlet. Eluatet bringas i kontakt med aluminiumoxid och det absorberade antibiotikumet elueras sedan fran denna. Det har visat sig, att cephalosporin C är narvarande tillsammans med cephalosporin N i det eluat, vilket erhalles fran aluminiumoxiden. Detta eluat ut- ddrfOr ett utgangsmaterial for cephalosporin C. Andra ramaterial for cephalosporin C utgoras av sjalva mdsken eller av losningar eller rapreparat erhallna av denna. Fackmannen kan ldtt bestdmma, under vilket reningsstadium vid nagot visst forfaramle cephalosporin N kan utvinnas, utan att cephalosporin C elimineras. Ett rApreparat av cephalosporin N kan salunda utsdttas for inverkan av ett lampligt penicillinaspreparat eller halls vid ett pH av 2,5-5 och sedan provas ph aterstaende aktivitet mot lampliga bakterier, exempelvis B.coli. 2- - Cephalosporin C är surt till sin natur. Bade den fria syran och dess natriumsalt aro lattlosliga i vatten och olosliga i aceton eller eter. En vattenlosning av natriumsaltet [ale + 103° uppvisar 1 y en absorption vid 260 ma med E= 200. 1 cm Cephalosporin C innehaller kol, \rate, syre, kvdve och svavel men icke halogen eller fosfor. Elementaranalys av natriumsaltet och den fria syran ha gett foljande resultat: Natrumsaltet: Punnet: C, 39,5, 40,0; H, 4,8, 5,2; N, 8,9; S, 6,2; Na, 4,9 %. Ekvi. (titratering) 480 ± 15. Molvikt enligt rontgenkristallografisk analys 470 1 15. The above-mentioned British patent specification 745 208 comprises i.a. a. a process for purifying cephalosporin N by separating the mycelium from the liquid, subsequent adsorption of cephalosporin N from the clear liquid ph activated carbon and darph following elnation of the antibiotic substance from the adsorbent. The eluate is contacted with alumina and the absorbed antibiotic is then eluted therefrom. It has been found that cephalosporin C is present together with cephalosporin N in the eluate obtained from the alumina. This eluate is derived from a starting material for cephalosporin C. Other raw materials for cephalosporin C consist of the liquid itself or of solutions or preparations obtained therefrom. Those skilled in the art can readily determine during which stage of purification at some particular precursor cephalosporin N can be recovered without eliminating cephalosporin C. A preparation of cephalosporin N can thus be exposed to the action of a suitable penicillin preparation or maintained at a pH of 2.5-5 and then the remaining activity against suitable bacteria, for example B. coli, is tested. 2- - Cephalosporin C is acidic in nature. Both the free acid and its sodium salt are readily soluble in water and insoluble in acetone or ether. An aqueous solution of the sodium salt [ale + 103 ° shows 1 y an absorption at 260 ma with E = 200. 1 cm Cephalosporin C contains carbon, \ rate, oxygen, nitrogen and sulfur but not halogen or phosphorus. Elemental analysis of the sodium salt and the free acid have given the following results: The sodium salt: Found: C, 39.5, 40.0; H, 4.8, 5.2; N, 8.9; S, 6.2; Na, 4.9%. Ekvi. (titration) 480 ± 15. Molecular weight according to X-ray crystallographic analysis 470 1 15.

C161-102N2SNa, 2 H20 krdver C, 40,5; H, 5,1; N, 8,9; S, 6,7; Na 4,9 %, molvikt 473. C161-102N2SNa, 2 H2 O requires C, 40.5; H, 5.1; N, 8.9; S, 6.7; Na 4.9%, molecular weight 473.

Fri syra: Funnet: C, 44,4; H, 5,6; N, 9,8; S, 7,3 %. C16112108N2S - H20 kraver G, 44,5; H, 5,3; N, 9,7; S, 7,4 %. Free acid: Found: C, 44.4; H, 5.6; N, 9.8; S, 7.3%. C16112108N2S - H2O collars G, 44.5; H, 5.3; N, 9.7; S, 7.4%.

Analysvardena visa, att cephalosporin C kan ha bruttoformeln C16H2102N3S. Denna formel dr emellertid endast preliminar och kan behova andras senare. The assay values show that cephalosporin C may have the gross formula C16H2102N3S. However, this formula is only preliminary and may need others later.

Cephalosporin C ger ninhydrinreaktion. Elektrometrisk titrering visar, att amnet utgOr en monoaminodikarboxylsyra med tvâ syragrupper med lagre pH-varden an 2,6 och 3,1 samt en basisk grupp med ett pK-varde av 9,8. Da dmnet underkastas jonofores pa papper i en kollidinacetatbuffert vid pH 7, migrerar det till anoden med ungefar samma hastighet som cephalosporin N. Cephalosporin C produces ninhydrin reaction. Electrometric titration shows that the substance is a monoaminodicarboxylic acid with two acid groups with lower pH values of 2.6 and 3.1 and a basic group with a pK value of 9.8. When the substance is subjected to ionophoresis on paper in a collidine acetate buffer at pH 7, it migrates to the anode at approximately the same rate as cephalosporin N.

Det infraroda spektrumet for natriumsaltet av cephalosporin C (i paraffinpasta) visar band vid foljande vaglangder: 2,94 ft, 3,06 au (NH), 5,77 it (ester- eller laktongruppering), 6,0ti och 6,57 ft (C = 0 av mono- substituerad amid), 6,29 ,a (-000-), 7,17 ,a och 7,36 ja (isopropylgrupp). Uppgifterna Mom parentes utgara tankbara tolkningar. Natriumsal- tet av cephalosporin C uppvisar aven ett band vid 5,61 pt. Ett band Mom detta omrade uppvisas av cephalosporin N och av natriumbensylpenicil- lin och hanfores vid den sistnamnda foreningen till C = 0-gruppen i det smalta fl-laktamtiazolidinringsystemet (Thompson, Brattain, Randall och 'Rasmussen, The Chemistry of Penicillin, kapitel 13, Princeton University Press, 1949). The infrared spectrum of the sodium salt of cephalosporin C (in paraffin paste) shows bands at the following wavelengths: 2.94 ft, 3.06 au (NH), 5.77 it (ester or lactone grouping), 6.0ti and 6.57 ft (C = O of mono-substituted amide), 6.29, α (-000-), 7.17, α and 7.36 α (isopropyl group). The information in parentheses is a conceivable interpretation. The sodium salt of cephalosporin C also shows a band at 5.61 pt. A band Mom this area is shown by cephalosporin N and by sodium benzylpenicillin and is introduced at the latter compound to the C = O group in the narrow β-lactam thiazolidine ring system (Thompson, Brattain, Randall and Rasmussen, The Chemistry of Penicillin, Chapter 13, Princeton University Press, 1949).

I motsats till cephalosporin N och bensylpenicillin ãr cephalosporin C stabilt i vattenlosning vid pH 2,5. Amnet inaktiveras emellertid snabbt vid pH 12. Sedan det hade Milts vid pH 12 under 2 h, visade atertitrering, att det hade bildats tva syragrupper per mol. Under liknande forhallanden friges endast en syragrupp per mol av cephalosporin N och av bensylpenicillin. Cephalosporin C dr stabilare i ndrvaro av vissa tungmetalljoner, sasom Cu+ +, Pb+ + och Zn++, an cephalosporin N eller bensylpenicillin. In contrast to cephalosporin N and benzylpenicillin, cephalosporin C is stable in aqueous solution at pH 2.5. However, the substance is rapidly inactivated at pH 12. After having Milts at pH 12 for 2 hours, atertitration showed that two acid groups per mole had formed. Under similar conditions, only one acid group per mole of cephalosporin N and of benzylpenicillin is released. Cephalosporin C is more stable in the presence of certain heavy metal ions, such as Cu ++, Pb ++ and Zn ++, than cephalosporin N or benzylpenicillin.

Vid hydrolys med syra (1-N HC1 under 8 h vid 110° C) avspaltar cephalosporin C liksom cephalosporin N koldioxid och en aminosyra, vii-ken forhdlIer sig pal samma satt som a-aminoadipinsyra pa papperskromatogram. Den produkt, som erhalles da cephalosporin C far reagera med 1,2,4-fluordinitrobensen, ger vid hydrolys en produkt, vilken forhaller sig ph samma satt som dinitrofenylderivatet av a-arninoadipinsyra. Det verkar darfor som om a-aminogruppen i a-amingadipinsyra dr fri i cephalosporin C och som am aven a-karboxylgruppen aven är fri (eftersom denna aminogrupp uppvisar ett pK-varde av 9,8). Upon hydrolysis with acid (1-N HCl for 8 hours at 110 ° C), cephalosporin C as well as cephalosporin N cleave carbon dioxide and an amino acid, which is similar to α-aminoadipic acid on paper chromatograms. The product obtained when cephalosporin C is reacted with 1,2,4-fluoroditrobenzene gives on hydrolysis a product which behaves in the same manner as the dinitrophenyl derivative of α-arninoadipic acid. It therefore appears that the α-amino group of α-amingadipic acid is free in cephalosporin C and that the α-carboxyl group is also free (since this amino group has a pK value of 9.8).

Nagra antydningar ha icke erhallits pa bildning av nagon starre mangd penicillamin (fl-tiolvalin) vid hydrolys av cephalosporin C. Hydrolys av den produkt, som erhalles av amnet vid hydrogenolys med raneynickel, gay aminosyror, vilka uppforde sig sasom a-aminoadipinsyra respektive valin pa papperskromatogram. No indications have been obtained for the formation of any greater amount of penicillamine (fl-thiolvaline) on hydrolysis of cephalosporin C. Hydrolysis of the product obtained by the substance by hydrogenolysis with raney nickel, gay amino acids, which behaved as α-aminoadipic acid and valine, respectively. paper chromatogram.

Cephalosporin C uppvisar en aktivitet av samma styrka mot ett stort antal grampositiva och gramnegativa bakterier. Amnet dr mindre verksamt an cephalosporin N mot Staph. Aureus och Salm. typhi in vitro, eftersom det uppvisar en aktivitet av 8-10 enheter per meg. (den enhet, som anges av Abraham, Newton och Hale, 1954, Biochem. J. 58, 94). Det har ungefar samma aktivitet som cephalosporin N mot en stam av Bact. coll. Cephalosporin C exhibits an activity of the same potency against a large number of gram-positive and gram-negative bacteria. Amnet dr less effective an cephalosporin N against Staph. Aureus and Salm. typhi in vitro, as it exhibits an activity of 8-10 units per meg. (the unit, cited by Abraham, Newton and Hale, 1954, Biochem. J. 58, 94). It has about the same activity as cephalosporin N against a strain of Bact. coll.

Amnets toxicitet liar icke kunnat bedomas genom fullstandiga biologiska forsOk men antages vara lag, eftersom moss kunna ges minst 10 mg av det renade materialet intravenOst utan att synas lida av skadliga verkningar. The toxicity of the substance could not be assessed by complete biological tests but is assumed to be legal, as moss can be given at least 10 mg of the purified material intravenously without appearing to suffer from adverse effects.

Cephalosporin C kan separeras &En en blandning av densamma med cephalosporin N genom att blandningen underkastas fordelning mellan tva losningsmedel, vilka bdgge dro i stand att upplosa bkle cephalosporin N och cephalosporin C. Varje lampligt Isningsmedelssystem kan anvandas, dar fordelningskoefficienten är gynnsam vid de pHvarden, vid vilka de bagge antibiotika aro stabila. Cephalosporin N ar instabilt vid pH-varden under 5, medan cephalosporin C Or stabilt aven vid sa laga pH-varden som 2,5. Da man. enligt uppfinningen uppoffrar cephalosporin-N-aktiviteten, kan fordelningen genomforas vid pH-varden, vid vilka endast cephalosporin C Or stabilt. Cephalosporin C can be separated & A a mixture of the same with cephalosporin N by subjecting the mixture to distribution between two solvents, both of which were able to dissolve both cephalosporin N and cephalosporin C. which the ram antibiotics are stable. Cephalosporin N is unstable at pH below 5, while cephalosporin C Or is stable even at as low as 2.5. Da man. according to the invention sacrifices the cephalosporin N activity, the distribution can be carried out at the pH value, at which only cephalosporin C Or is stable.

Enligt uppfinningen kan salunda cephalosporinet N i blandningen overfOres till cephalosporinN-penillinsyra och den bildade blandningen be- handlas for avskiljning av cephalosporin C frau densamma, exempelvis genom losningsfraktione- ring, fraktionerad absorption pa en fast absor- bent, sasom aluminiumoxid eller en anjonbytare, genom att penillinsyra omsattes till ett olosligt derivat, eller genom nagon kombination av dessa bdgge metoder. Det lampligaste sattet att omsatta cephalosporin N till dess penillinsyra Or att haila blandningen vid ett pH, vid vilket cephalosporin N är instabilt. Omsd.ttningen kan salunda astadkommas genom att blandningen helt enkelt — —3 Mlles vid pH 3 under 2 h vid en temperatur av 37° C. According to the invention, the cephalosporin N in the mixture can thus be transferred to cephalosporin N-penillic acid and the resulting mixture treated for separating cephalosporin C therefrom, for example by solution fractionation, fractional absorption on a solid absorbent, such as alumina or an anion exchanger, that penillic acid is converted to an insoluble derivative, or by any combination of these two methods. The most convenient way is to convert cephalosporin N to its penillic acid Or to dilute the mixture at a pH at which cephalosporin N is unstable. The reaction can thus be effected by simply mixing the mixture at pH 3 for 2 hours at a temperature of 37 ° C.

Foljande forfaranden for separering av cephalosporin C fran cephalosporin-N-penillinsyra ha vi-sat sig ge goda resultat. - 1. En vattenlosning av blandningen sattes till en pelare av ett anjonbytande harts, sasom »amberlite IR4B (XE-59)», varefter elueringen genomfores med en utspadd syra, nagon lamplig buffertlosning, sasom en vattenlosning av ammoniumformiat eller ammoniumacetat, med ett pH av 3,2-5,0, eller en vattenlosning av en ter-. tiar bas, sasom pyridin, delvis neutraliserad med svavelsyra eller oxalsyra. Ett band, som bestir av cephalosporin-N-penillinsyra uttrader ur pelaren fore ett band bestaende av cephalosporin C. The following procedures for separating cephalosporin C from cephalosporin-N-penillic acid have been found to give good results. An aqueous solution of the mixture was added to a column of an anion-exchange resin, such as "amberlite IR4B (XE-59)", after which the elution was carried out with a dilute acid, some suitable buffer solution, such as an aqueous solution of ammonium formate or ammonium acetate, having a pH of 3.2-5.0, or an aqueous solution of a ter-. tiar base, such as pyridine, partially neutralized with sulfuric acid or oxalic acid. A band consisting of cephalosporin-N-penillic acid emerges from the column of a band consisting of cephalosporin C.

En vattenlOsning av blandningen underkastas i en fOrdelningsmaskin en motstromsfordelning under svagt sura fithallanden i ett tvafassystem av vatten och fenol (eller nagon lamplig, substituerad fenol, sasom kresol eller nagon xylenol). Fordelningskoefficienterna i systemet kunna eventuellt modifieras genom tillsats av en lamplig mangd av nagot organiskt losningsmedel, exempelvis koltetraklorid. Systemets pH installes ph 2-5 genom tillsats av attiksyra eller ammoniumacetat eller ammoniumformiatbuffert. Overforingar genomfOras, tills cephalosporin C och cephalosporin-N-penillinsyra ha bildat separata band. Forhallandena installas lampligen sa, att cephalosporin C uttages fran maskinen i vattenfasen. An aqueous solution of the mixture is subjected in a distribution machine to a countercurrent distribution under weakly acidic phytallands in a two-phase system of water and phenol (or any suitable, substituted phenol, such as cresol or any xylenol). The partition coefficients in the system can possibly be modified by adding an appropriate amount of some organic solvent, for example carbon tetrachloride. The pH of the system is installed pH 2-5 by adding acetic acid or ammonium acetate or ammonium formate buffer. Transfers are performed until cephalosporin C and cephalosporin-N-penillic acid have formed separate bands. The conditions are suitably installed so that the cephalosporin C is taken out of the machine during the aqueous phase.

En vattenlosning av blandningen uppsattes pa en pelare av syratvattad aluminiumoxid och elueringen genomfores med utspadd lut, sasom 0,01 N natronlut. Cephalosporin C uttrader frail pelaren som en losning av sitt natriumsalt fore cephalosporin-N-penillinsyra. An aqueous solution of the mixture was placed on a column of acid-quenched alumina and the elution was carried out with dilute lye, such as 0.01 N sodium hydroxide solution. Cephalosporin C emerges from the pillar as a solution of its sodium salt for cephalosporin-N-penillic acid.

En vattenbisning av merkuriklorid sattes till en losning innehallande en rhblandning av cephalosporin C och cephalosporin-N-penillinsyra, vilken sistnamnda forening omsattes till en pe- nillamin, vilken utfalles som en merkaptid. Den overstaende losningen innehaller ratt cephalosporin C. An aqueous bit of mercuric chloride was added to a solution containing a mixture of cephalosporin C and cephalosporin-N-penillic acid, the latter compound being converted to a penillamine, which precipitated as a mercaptide. The above solution contains steering wheel cephalosporin C.

Losningar av fritt cephalosporin C, vilka ha erhallits genom nagot av foregaende forfarings- satt, kunna indrivas till torrhet i vakuum och cephalosporinet C ledas genom en annan anjonbytarpelare for ytterligare rening. Det renade cephalosporinet C kan omsattas till natriumsaltet genom upplbsning i vatten och installning av pH pa 6,0 med natriumhydroxid. Solutions of free cephalosporin C, which have been obtained by any of the foregoing procedures, can be forced to dryness in vacuo and the cephalosporin C passed through another anion exchange column for further purification. The purified cephalosporin C can be converted to the sodium salt by dissolving in water and installing pH 6.0 with sodium hydroxide.

Losningar av natriumsaltet av cephalosporin G, vilka ha erhallits ph nagot av dessa satt, kunna avfargas om sh. Or nodvandigt under anvandning av aktivt trakol, och koncentreras i vakuum. Cephalosporinets C natriumsalt bildar monoklina kristaller innehallande kristallvatten. Pet kan om- kristalliseras ur vattenhaltig etanol eller propanol. Vid torkning i vakuum vid rumstemperatur for- lorar antibiotikumet kristallvattnet, som snart upptages igen vid kontakt med laboratorieluften. Uppfinningen belyses av fOljande exempel. Solutions of the sodium salt of cephalosporin G, which have been obtained ph any of these sat, may be decolorized if sh. Or necessary using active trachol, and concentrated in vacuo. The sodium salt of cephalosporin C forms monoclinic crystals containing crystal water. The pet can be recrystallized from aqueous ethanol or propanol. When dried in vacuo at room temperature, the antibiotic loses the crystal water, which is soon taken up again by contact with the laboratory air. The invention is illustrated by the following examples.

Exempel 1. 6,9 g ratt cephalosporin N erhallet vid daring fran alumininmoxid, sasom beskrives i den brittiska patentskriften 745 208 med en styrka av 20 enheter/mg, kistes i 110 ml vatten. Ett prov togs ut fOr att anyandas som referens- prov vid efterfoljande spektroskopiska matningar. 10 N saltsyra (vanligen cirka 1 ml) tillsattes, tills losningen fick ett pH av 2,7-3,0. Losningen varm- des sedan till 37° C och prov logos ut varje halvtimma. Proven spaddes med vatten till losningar innehallande 0,075 mg/ml och den optiska tatheten vid 240 my fOr dessa losningar mattes i forhallande till referensprovet, som hade utspatts pa samma salt. Reaktionen antogs vara fullstandig, da flagon ytterligare okning i den optiska tatheten vid 240 my icke kunde iakttagas (120180 min). Okningen i tathet vid 240 my var vanligen c:a 0,3 tathetsenheter, da en 1 cm cell och en koncentration av 0,075 mg/ml utnyttjades. DA omsattningen av cephalosporin-N-komponenten till pennillinsyra var fullstandig, frystorkades lOsningen, varvid man fick 7,0 g av blandningen. Example 1. 6.9 g of steering wheel cephalosporin N obtained by trembling from alumina, as described in British Patent Specification 745,208 with a strength of 20 units / mg, were boxed in 110 ml of water. A sample was taken to be used as a reference sample in subsequent spectroscopic feeds. 10 N hydrochloric acid (usually about 1 ml) was added until the solution reached a pH of 2.7-3.0. The solution was then heated to 37 ° C and samples were logged every half hour. The samples were diluted with water to solutions containing 0.075 mg / ml and the optical density at 240 microns for these solutions was measured in relation to the reference sample, which had been diluted on the same salt. The reaction was assumed to be complete, as further increase in the optical density at 240 microns could not be observed (120,180 min). The increase in density at 240 microns was usually about 0.3 density units, when a 1 cm cell and a concentration of 0.075 mg / ml were used. When the conversion of the cephalosporin N component to pennilic acid was complete, the solution was lyophilized to give 7.0 g of the mixture.

Ett anjonbytarharts (Amberlite XE 59) buffrat med 0,2 M ammoniumformiat vid pH 3,0-3,2 framstalldes ph det salt, som beskrives av Hirs, Moore och Stein (1952, J. Biol. Chem., 195, 699). En pelare pa 59 x 4 cm packades med det buff-. rade hartset, varefter 500 ml av 0,2 M ammoniumformiat innehallande 0,5 % tiodiglykol fick strOmma genom pelarna. 3,5 g av blandningen av cephalosporin C och cephalosporin-N-penillinsyra lostes i 30 ml 0,2 M buffert och losningens pH installdes sa, att det var 0,2 pH-enheter hOgre an for bufferten i pelaren. Denna lasning halides ph pelaren i 3 portioner pa 10 ml. Pelarens genomstromningshastighet installdes sa, att varje portion pa 10 ml behOvde 10-15 min for att sjunka in i pelaren. DUningen spolades sedan in i pelaren med 2 x 10 ml 0,2 M buff ert innehallande 0,5 °A, tiodiglykol. Pelaren fylldes sedan med samma buffertlOsning och anslots till en behallare for konstant tryck. Pelarens genomstromningshastighet installdes sa, att man kunde uppsamla en fraktion pa 20 ml var trettionde minut. An anion exchange resin (Amberlite XE 59) buffered with 0.2 M ammonium formate at pH 3.0-3.2 was prepared in the salt described by Hirs, Moore and Stein (1952, J. Biol. Chem., 195, 699). . A pillar of 59 x 4 cm was packed with the buff-. the resin, after which 500 ml of 0.2 M ammonium formate containing 0.5% thiodiglycol was allowed to flow through the columns. 3.5 g of the mixture of cephalosporin C and cephalosporin-N-penillic acid was dissolved in 30 ml of 0.2 M buffer and the pH of the solution was adjusted so that it was 0.2 pH units higher than the buffer in the column. This solution is halided ph pillar in 3 portions of 10 ml. The flow rate of the column was adjusted so that each 10 ml portion needed 10-15 minutes to sink into the column. The duct was then flushed into the column with 2 x 10 ml of 0.2 M buffer containing 0.5 ° A, thiodiglycol. The column was then filled with the same buffer solution and connected to a constant pressure container. The flow rate of the column was adjusted so that a fraction of 20 ml could be collected every thirty minutes.

Prov frail var fjarde fraktion logos ut och spaddes 10 ganger med vatten. De utspadda losningarnas optiska tathet mattes vid 240 m,u, och 260 my i fOrhallande till ett pa samma satt utspatt prov av buffertlosningen. Cephalosporin C Aterfanns huvudsakligen i fraktionerna nr 96-118. Sample frail was the fourth fraction logos out and was diluted 10 times with water. The optical density of the diluted solutions was measured at 240 m, u, and 260 microns in relation to a similarly diluted sample of the buffer solution. Cephalosporin C was found mainly in fractions Nos. 96-118.

Fraktionerna 96-118 slogos samman och koncentrerades till c:a 60 ml i en roterande vakuumevaporator vid en temperatur under 25° C. Koncentratet drevs sedan in till en tjock sirap i en frystorkningsapparat. Sirapen tvattades tva ganger med aceton for avlagsnande av tiodiglykolen. En blandning av ammoniumformiat och ammoniumsaltet av cephalosporin C aterstod. Ammoniumformiatet kunde avlagsnas genom antingen A) sublimering vid Mgt vakuum eller B) elektrofores. Fractions 96-118 were combined and concentrated to about 60 ml in a rotary vacuum evaporator at a temperature below 25 ° C. The concentrate was then concentrated to a thick syrup in a lyophilizer. The syrup was washed twice with acetone to remove the thiodiglycol. A mixture of ammonium formate and the ammonium salt of cephalosporin C remained. The ammonium formate could be removed by either A) sublimation at Mgt vacuum or B) electrophoresis.

A) Den fasta massa, som hterstod efter tvatt- 4— — ningen med aceton, lostes i nagra f ml vatten och overfordes till en sublimeringsapparat. Sublimeringen genomfordes pa det satt, som beskriYes av Hirs, Moore och Stein (1952, J. Biol. Chem. 195, 699). Aterstoden fran sublimeringen utgjordes huvudsakligen av ammoniumsaltet av cephalosporin C. Saltet lostes i 2-3 ml vatten och losningen fick stromma genom en liten pelare (0,5 x x 0,5 cm) av aktivt kol f6r avlagsnande av fargamnen. DA perkolatet lick indunsta langsamt, kristalliserade produkten. A) The solid mass which remained after washing with acetone was dissolved in a few ml of water and transferred to a sublimation apparatus. The sublimation was performed in the manner described by Hirs, Moore and Stein (1952, J. Biol. Chem. 195, 699). The residue from the sublimation consisted mainly of the ammonium salt of cephalosporin C. The salt was dissolved in 2-3 ml of water and the solution was allowed to flow through a small column (0.5 x x 0.5 cm) of activated carbon to remove the dyes. The leachate seemed to evaporate slowly, crystallizing the product.

B) Den fasta massa, som aterstar efter tvattningen med aceton, lOstes i 25 ml vatten och inftirdes i den neutrala kammaren i en fyrkammarcell (Synge, 1951, Biochem. J. 49, 642). Cellen var forsedd med en kylslinga, genom vilken alkohol pa — 5' C pumpades. Attiksyra- och ammoniakkamrarna byttes var tredje timme. Avsaltningen var vanligen fullbordad pa 12-16 h, (la spanningar Tipp till 500 V anvandes. Liisningarna Iran attiksyrakamrarna slogos samman och frystorkades. Produkten, som bestod ay den fria syran av cephalosporin C fororenad med spar av attiksyra, befriades fran attiksyra genom upplosning i en ringa mangd vatten, fanning med ett stort overskott av aceton och omroring av fallningen med torr aceton. Den fria syran av cephalosporin C lostes sedan i vatten och neutraliserades med 2N .NaOH (0,3-0,2 ml). DA losningen lick avdunsta langsamt, kristalliserade natriumsaltet. Kristallerna befriades frail icke kristalliserat slemamne genom tvattning med 70-procentig etanol och omkristalliserades sedan ur vattenhaltig alkohol. I.:tbytet av omkristalliserat material var 100 10/ mg. Vid 260 my var E200. 1 cm Exempel 2. Ratt cephalosporin N (4 mg innehallande 22 enheter/mg) lostes i 30 ml vatten och lasningens pH installdes pa 3,0 med 2N HC1. Losningen halls yid 37' C under 2,5 h och leddes sedan genom en 14 cm lang pelare innehallande 10 g aluminiumoxid (Savory & Moore Ltd., London. For Chromatographic Analysis). Aluminiumoxiden hade forut omrorts med tillracklig mangd utspadd saltsyra for att den overstaende vatskans pH skulle bringas till jamvikt vid pH 4,8. B) The solid mass remaining after washing with acetone was dissolved in 25 ml of water and introduced into the neutral chamber of a four-chamber cell (Synge, 1951, Biochem. J. 49, 642). The cell was equipped with a cooling loop, through which alcohol at - 5 ° C was pumped. The acetic acid and ammonia chambers were changed every three hours. The desalination was usually completed in 12-16 hours, (Tipping voltages up to 500 V were used. The solutions in the attic acid chambers were combined and lyophilized. a small amount of water, finding with a large excess of acetone and stirring the precipitate with dry acetone, the free acid of cephalosporin C was then dissolved in water and neutralized with 2N NaOH (0.3-0.2 ml). The crystals were liberated from uncrystallized slime by washing with 70% ethanol and then recrystallized from aqueous alcohol. The yield of recrystallized material was 100 .mu.g / mg. Steering wheel cephalosporin N (4 mg containing 22 units / mg) was dissolved in 30 ml of water and the pH of the solution was adjusted to 3.0 with 2N HCl, the solution was kept at 37 ° C for 2.5 hours and then led to give nom a 14 cm long pillar containing 10 g alumina (Savory & Moore Ltd., London. For Chromatographic Analysis). The alumina had previously been stirred with a sufficient amount of dilute hydrochloric acid to bring the pH of the supernatant to equilibrium at pH 4.8.

Da all losningen hade satts till aluminiumoxiden, upptradde ett tunt, brunt band ur pelarens ovre ande och ett svagt gult band strackte sig nedat fran detta till c:a 2/3 av pelarens langd. Endast spar av ninhydrinpositivt material upptradde i perkolatet. Pelaren tvattades med 20 ml vatten, varefter elueringen borjade med 0,01N NaOH. Eluatet uppsamlades i fraktioner pa 5 ml. Stromningshastigheten var 1 ml/min. Utslackningen i dessa fraktioner vid 240 my och 260 my mattes i en Beckmans spektrofotometer. Fran och med fraktionen 13 borjade absorptionen vid bagge vaglangderna att stiga hastigt. Fran fraktionerna 13-17, vilka innehollo cephalosporin C, blev absorptionen storre Yid 260 my an vid 240 my. Vid fraktionen 18 upptradde en pltitslig Okning i den relativa absorptionen vid 240 my pa. grund av upp tradandet i eluatet av cephalosporin-N-penillinsyra. Vid fraktion 21 upptradde ett gult pigment I eluatet. When all the solution had been added to the alumina, a thin, brown band appeared from the upper spirit of the column and a faint yellow band stretched down from this to about 2/3 of the length of the column. Only traces of ninhydrin-positive material appeared in the leachate. The column was washed with 20 ml of water, after which the elution started with 0.01N NaOH. The eluate was collected in 5 ml fractions. The flow rate was 1 ml / min. The leaching in these fractions at 240 my and 260 my was measured in a Beckmans spectrophotometer. As of fraction 13, the absorption at ram vaginal lengths began to rise rapidly. From fractions 13-17, which contained cephalosporin C, the absorption was greater than 260 microns at 240 microns. At fraction 18, a sudden increase in relative absorption occurred at 240 microns pa. due to the appearance in the eluate of cephalosporin-N-penillic acid. At fraction 21, a yellow pigment appeared in the eluate.

Fraktionerna 13-17 (pH 5,0) slogos samman och koncentrerades i vakuum till 2 ml. Pigmentet avlagsnades Iran den resulterande losningen genom att denna leddes genom en liten pelare av aktivt kol (0,5 cm diameter och 3 cm hojc1), vii-ken forut hade tvattats med vatten. Vid koncentrering av perkolatet i vakuum hardnade det till en kristalliserad massa av cephalosporin C. Produkten vagde 33 mg. Den inneholl en mindre mangd icke kristalliserade slemainnen och matningen av dess absorption yid 260 my visade narvaron av 25 mg cephalosporin C. Kristallerna avskildes fran slemamnet genom omroring med en. singe mangd 70-procentig etanol och filtrering. Den kristalliserade produkten omkristalliserades ur vattenhaltig propanol. Fractions 13-17 (pH 5.0) were combined and concentrated in vacuo to 2 ml. The pigment was removed from the resulting solution in Iran by passing it through a small column of activated carbon (0.5 cm diameter and 3 cm high), which had previously been washed with water. Concentration of the leachate in vacuo hardened to a crystallized mass of cephalosporin C. The product weighed 33 mg. It contained a small amount of non-crystallized mucus and the feed of its absorption at 260 microns showed the presence of 25 mg of cephalosporin C. The crystals were separated from the mucus by stirring with a. singe mangd 70% ethanol and filtration. The crystallized product was recrystallized from aqueous propanol.

Exempel 3. Losningssystem. 5 1 vatten mattad med fenol, 4,5 1 fenol matted med vatten och 0,45 1 isattika blandades och lingo komma till jamvikt yid 20° C. Det byre skiktets pH var yid jamvikt 2,6 matt med glaselektrod. Example 3. Unloading system. 5 l of water matted with phenol, 4.5 l of phenol matted with water and 0.45 l of glacial acetic acid were mixed and lingo reached equilibrium at 20 ° C.

Fordelning. 7,3 g blandning av cephalosporinN-pennillinsyra och cephalosporin C erhallen pa samma Ott som enligt exempel 1 lostes i 80 ml av toppfasen och 40 ml av bottenfasen i losningssystemet. Bottenfasen, 20 ml, och toppfasen, 40 ml, av denna losning infordes i 'Oren »0» och »1» i en helt ay glas bestaende maskin for motstromsfOrdelning (Craig och Craig, 1950 Technique & Organic Chemistry, volym 3, kapitel 4). Toppskiktet, 40 ml, omsattes 100 ganger under anvandfling av den grundlaggande proceduren, med efterfOljande 300 avtappningar av det byre skiktet, 40 ml, fran roret »100». Distribution. 7.3 g of a mixture of cephalosporin N-pennillic acid and cephalosporin C obtained on the same Ott as in Example 1 were dissolved in 80 ml of the top phase and 40 ml of the bottom phase in the solution system. The bottom phase, 20 ml, and the top phase, 40 ml, of this solution were introduced into the 'Oren' 0 »and» 1 »of an all-in-glass machine for countercurrent distribution (Craig and Craig, 1950 Technique & Organic Chemistry, Volume 3, Chapter 4). ). The top layer, 40 ml, was reacted 100 times using the basic procedure, followed by 300 drains of the top layer, 40 ml, from the tube "100".

Analys av fraktionerna. Ett prov pa 0,2 ml togs ut Iran var tionde fraktion av den avtappade serien och den fArgtathet, som utvecklades vid upphettning med ninhydrin (0,5 ml), mattes fotometriskt pa det Ott, som anges av Moore och Stein, 1948, J. Biol Chem. 176, 367. DA de varden pa den optiska tatheLen, som erh011os pA detta satt, aysattes mot fraktionens nummer, upptacktes ett band innehallande cephalosporin-Npenillinsyra i fraktionerna 51-120 och ett band innehallande cephalosporin C i fraktionerna 190300. Det varde for fordelningskoefficienten (K = = konc. i vattenfasen/konc. i fenolfasen) for cephalosporin C, som beraknas frail laget for bandets topp, var 0,2, inedan vardet for cephalosporin-N-penillinsyra var 0,63. Analysis of the fractions. A sample of 0.2 ml was taken from Iran every tenth fraction of the drained series, and the fatigue which developed on heating with ninhydrin (0.5 ml) was measured photometrically at the Ott, given by Moore and Stein, 1948, J Biol Chem. 176, 367. When the values of the optical particle obtained in this way were set against the number of the fraction, a band containing cephalosporin-Npenillic acid in fractions 51-120 and a band containing cephalosporin C in fractions 190300 were detected. K = = conc. In the aqueous phase / conc. In the phenol phase) for cephalosporin C, which is calculated from the layer for the top of the band, was 0.2, while the value for cephalosporin-N-penillic acid was 0.63.

De uttagna fraktionerna 200-300 slogos samman och koncentrerades till c:a 400 ml (400 ml vattenskikt och 100 ml fenolskikt) i en roterande vakuumevaporator. Koncentratet halides sedan i en skiljetratt och skakades med 400 ml koltetra- klorid. Sedan skiktet hade separerat, avtappades koltetrakloridfasen, medan yattenfasen extraherades tre ganger med samma volym bensen. Den vattenhaltiga resten koncentrerades till c:a 100 ml i en roterande evaporator och frystorkades sedan. Spar av attiksyra avlagsnades Iran produk- — — ten genom att denna uppltistes i en ringa mangd vatten och cephalosporin C (fri syra) falldes med overskott av aceton. Fallningen tvattades med torr aceton. The withdrawn fractions 200-300 were combined and concentrated to about 400 ml (400 ml water layer and 100 ml phenol layer) in a rotary vacuum evaporator. The concentrate was then halided in a separatory funnel and shaken with 400 ml of carbon tetrachloride. After the layer had separated, the carbon tetrachloride phase was drained, while the yatten phase was extracted three times with the same volume of benzene. The aqueous residue was concentrated to about 100 ml in a rotary evaporator and then lyophilized. Traces of attic acid were removed from the Iran product by dissolving it in a small amount of water and cephalosporin C (free acid) was precipitated with excess acetone. The precipitate was washed with dry acetone.

Den fria syran lostes i en ringa mangd vatten och neutraliserades sedan med 2N NaOH (0,5- 0,6 ml). Natriumsaltet av cephalosporin C kri- stalliserade, cla den neutraliserade losningen fick avdunsta langsamt. Kristallerna tvattades med 70-procentig etanol, varigenom icke kristalliserat material avlagsnades. Utbyte 168 mg. Detta material omkristalliserades ur vattenhaltig propanol. Exempel 4. En vattenlosning av ran cephalosporin C, surgjordes till pH 2,5 och holls vid. 37° C under 2 h. Cephalosporinet N var di full- standigt inaktiverat. Losningen frystorkades, sedan dess pH hade installts ph 5,0. Produkten (600 mg med 0,45 enheter per mg) sattes till 3 ml pyridin-acetatbuffert pH 5,0, 150 ml 2 M attiksyra, 250 ml N-pyridin och 600 ml vatten, var- efter nagot olosligt material avlagsnades genom centrifugering. Den bildade, klara losningen (pH 5,0) sattes sakta i tvi portioner till ovre delen av en pelare (1,9 x 20 cm) Amberlite IR4B (korn- storlek svarande mot sikt nr 200-400). Hartset buffrades till pH 5,0 med pyridinacetat genom tvattning av hartsets acetatform med pyridinacetatbuffert, som hade framstalas enligt ovan, pa ett filter, tills den tillfOrda och den avgaende bufferten hade samma pH, dvs. 5,0. The free acid was dissolved in a small amount of water and then neutralized with 2N NaOH (0.5-0.6 ml). The sodium salt of cephalosporin C crystallized, cla the neutralized solution was allowed to evaporate slowly. The crystals were washed with 70% ethanol, whereby non-crystallized material was deposited. Yield 168 mg. This material was recrystallized from aqueous propanol. Example 4. An aqueous solution of ran cephalosporin C, acidified to pH 2.5 and maintained at. 37 ° C for 2 hours. The cephalosporin N was completely inactivated. The solution was freeze-dried, since its pH had been installed at pH 5.0. The product (600 mg with 0.45 units per mg) was added to 3 ml of pyridine acetate buffer pH 5.0, 150 ml of 2 M acetic acid, 250 ml of N-pyridine and 600 ml of water, after which some insoluble material was removed by centrifugation. The resulting clear solution (pH 5.0) was slowly added in two portions to the upper part of a column (1.9 x 20 cm) Amberlite IR4B (grain size corresponding to sieve no. 200-400). The resin was buffered to pH 5.0 with pyridine acetate by washing the acetate form of the resin with pyridine acetate buffer, which had been prepared as above, on a filter, until the supplied and the outgoing buffer had the same pH, i.e. 5.0.

Sedan losningen av raft cephalosporin C hade flutit ned i pelaren, fOlj des den av tvâ tillsatser ph 2 ml pyridinacetatbuffert, varefter pelarens byre ankle anslots till en behallare for konstant tryck innehallande pyridinacetatbuffert. Behal larens niva installdes for erhallande av onskad stromningshastighet (9 ml/h). Donna stromnings- hastighet uppnaddes, di buffertens hojd i behallaren var endast nagra fa cm ovanfor pelarens bottenplatta. Effluatet uppsamlades i fraktioner pa 3 ml var tjugonde minut. After the discharge of the raft cephalosporin C had flowed down into the column, it was followed by two additions of 2 ml of pyridine acetate buffer, after which the upper ankle of the column was connected to a constant pressure container containing pyridine acetate buffer. The level of the tank was adjusted to obtain the desired flow rate (9 ml / h). Donna flow velocity was achieved, in that the height of the buffer in the container was only a few cm above the bottom plate of the column. The effluent was collected in 3 ml fractions every twenty minutes.

Alternerande fraktioner analyserades genom bestamning av antibakterieaktiviteten mot S. typhi pa pray, som bade neutraliserats med natronlut, samt aven genom en fotometrisk ninhydrinmetod (Moore och Stein, 1948, J. Biol. Chem. 176, 367). Cephalosporin C eluerades i fraktionerna nr 108. Dessa fraktioner slogos samman och koncentrerades i vakuum (vid en badtemperatur av 30° C) i en roterande evaporator. Aterstoden lostes i en ringa volym vatten och overfordes till en skid samt torkades Over natten vid vakuum Over KOH och 1320, varefter man icke kunde upptacka nagon lukt av pyridin eller attiksyra. Produkten lostes i en ringa mangd vatten (0,3 ml) och 10 ml aceton tillsattes. Fallningen centrifugerades at, omrordes med nagra fa ml aceton, centrifugerades pa nytt och torkades i vakuum, varvid man fick ett vitt pulver av den fria syran cephalosporin C. Donna fria syra lostes i 2 ml vat- ten till bildning av en lOsning med pH 3,0, varefter 0,49 ml 0,1 N NaOH tillsattes fOrsiktigt fran en byrett, tills pH hade stigit till 6,5. Den harvid bildade losningen av natriumsaltet av cephalosporin C frystorkades. Det torkade materialet kristalliserades genom upplOsning av detsamma i en ringa mangd vatten och langsam indunstning av losningen. Det torra, kristalliserade materialet (39 mg) befriades frail icke kristalliserade fOroreningar genom tvattning med en ringa mangd 70-procentig (v/v) etanol. Alternating fractions were analyzed by determining the antibacterial activity against S. typhi pa pray, which was both neutralized with sodium hydroxide solution, and also by a photometric ninhydrin method (Moore and Stein, 1948, J. Biol. Chem. 176, 367). Cephalosporin C was eluted in fractions No. 108. These fractions were combined and concentrated in vacuo (at a bath temperature of 30 ° C) in a rotary evaporator. The residue was dissolved in a small volume of water and transferred to a ski and dried overnight under vacuum over KOH and 1320, after which no odor of pyridine or acetic acid could be detected. The product was dissolved in a small amount of water (0.3 ml) and 10 ml of acetone was added. The precipitate was centrifuged, stirred with a few ml of acetone, centrifuged again and dried in vacuo to give a white powder of the free acid cephalosporin C. Donna free acid was dissolved in 2 ml of water to give a solution of pH 3 .0, after which 0.49 ml of 0.1 N NaOH was carefully added from a burette until the pH had risen to 6.5. The resulting solution of the sodium salt of cephalosporin C was lyophilized. The dried material was crystallized by dissolving the same in a small amount of water and slowly evaporating the solution. The dry crystallized material (39 mg) was freed from uncrystallized compounds by washing with a small amount of 70% (v / v) ethanol.

Exempel 5. En Riming av ratt cephalosporin C surgjordes till pH 2,5. Den Mills sedan vid 37° C under 2 h, varunder all cephalosporin-N-aktivitet fOrstordes. Losningen frystorkades, sedan dess pH hade installts pa 5,0. Produkten. (4 g med 0,08 enheter per mg) skakades med 8 ml pyridinacetatlosning med pH 5,0 (se exempel 7). Nagra fa' drop-par pyridin tillsattes for att halla losningens reaktion vid pH 5,0. Efter c:a 20 min centrifugerades losningen och den klara vatskan dekanterades ay. Fallningen skakades med ytterligare 4 ml buff ert och centrifugerades pa nytt, varefter den andra satsen av klarnad vatska (12 ml) i 4 portioner pa 3 ml infordes i en pelare pa 2 x 42 cm av Amberlite IR4B (79 % svarande mot sikt nr 40-60 och 20 % mot sikt nr 60-100). Hartset hade buff-rats med pyridinacetatbuffert (pH 5,0) sasom beskrives i exempel 7. LOsningen av raft cephalosporin C fOljdes av tva portioner ph 3 ml vardera av pyridinacetatbuffert, varefter pelaren drevs pa samma satt som enligt exempel 7. Example 5. A rhyme of steering wheel cephalosporin C was acidified to pH 2.5. The Mills then at 37 ° C for 2 hours, during which all cephalosporin N activity was increased. The solution was lyophilized after its pH had been set at 5.0. The product. (4 g with 0.08 units per mg) was shaken with 8 ml of pH 5.0 pyridine acetate solution (see Example 7). A few drops of pyridine were added to keep the reaction of the solution at pH 5.0. After about 20 minutes, the solution was centrifuged and the clear liquid was decanted ay. The precipitate was shaken with another 4 ml of buffer and centrifuged again, after which the second batch of clarified liquid (12 ml) in 4 portions of 3 ml was introduced into a 2 x 42 cm column of Amberlite IR4B (79% corresponding to screen no. 40). -60 and 20% towards visibility no. 60-100). The resin had been buffered with pyridine acetate buffer (pH 5.0) as described in Example 7. The solution of raft cephalosporin C was followed by two portions of 3 ml each of pyridine acetate buffer, after which the column was run in the same manner as in Example 7.

Cephalosporinet C aterfanns i effluatvolymen 280-500 ml. Materialet i effluatvolymen 387443 ml befriades frail pyridinacetatbuffert och falldes med aceton sasom beskrives i exempel 7, varvid man erholl 18 mg av den fria syraformen av cephalosporin C i orent tillstand. Den fria syran lostes i 2,0 ml vatten och 0,14 ml 0,1 N NaOH tillsattes, tills pH stag till 6,5. Da denna ltisning hade indunstat langsamt, utskildes nagot av materialet i kristalliserad form. Blandningen av kristalliserat och icke kristalliserat material tvattades med 40-procentig etanol pi ett filter, varvid man fick 2 mg av det kristalliserade natriumsaltet av cephalosporin C. Ur den Rr tvattningen anvanda etanolen erholls 14 mg av ett material med 2,5 enheter/mg. Den aterstaende lOsningen frail effluatvolymen 280-500 ml uppskattades innehalla 23 mg material med 2,5 enheter/mg. Cephalosporin C was found in the effluate volume of 280-500 ml. The 388,443 ml effluent volume was freed from pyridine acetate buffer and precipitated with acetone as described in Example 7 to give 18 mg of the free acid form of cephalosporin C in the crude state. The free acid was dissolved in 2.0 mL of water and 0.14 mL of 0.1 N NaOH was added until the pH stagnated to 6.5. As this liquid had evaporated slowly, some of the material was excreted in crystallized form. The mixture of crystallized and non-crystallized material was washed with 40% ethanol in a filter to give 2 mg of the crystallized sodium salt of cephalosporin C. From the Rr wash using the ethanol, 14 mg of a material of 2.5 units / mg were obtained. The remaining solution from the effluent volume of 280-500 ml was estimated to contain 23 mg of material at 2.5 units / mg.

Det ma framhallas, att de ovan beskrivna exemplen av foredragna utforingsformer endast ha till uppgift att belysa uppfinningen, samt att olika avvikelser kurma vidtagas utan att man darfor overskrider uppfinningens ram. Det ma i detta sammanhang omnamnas, att vilket som heist av de losningssystem, som ha anvants vid separering av cephalosporin C frail cephalosporin-N-penillinsyra genom motstromsfordelning, kan tillampas pa fordelningskromatografering, varvid en av faserna absorberas pa en barare, sasom kiselgur, eller att de kunna anvandas i en kontinuerlig extraktionspelare, exempelvis den som beskrives av Scheibel & Karr (Ind. Eng. Chem. 42, p. 1048, 1950). It should be emphasized that the above-described examples of preferred embodiments have only the task of illustrating the invention, and that various deviations are taken without exceeding the scope of the invention. It may be mentioned in this connection that any of the solution systems which have been used in separating cephalosporin C from cephalosporin-N-penillic acid by countercurrent distribution can be applied to partition chromatography, one of the phases being absorbed on a bar, such as diatomaceous earth, or that they can be used in a continuous extraction pillar, for example the one described by Scheibel & Karr (Ind. Eng. Chem. 42, p. 1048, 1950).

Det har namnts ovan, att cephalosporin C Or okansligt for penicillinas, dvs. att det forblir i 6— 192 926 — huvudsak opaverkat darav. Detta dr en mycket fordelaktig egenskap hos det nya antibiotikumet, emedan den Or detsamma vardefullt mot sa.dana mikroorganismer, som alstra penicillinas och darfor aro mer eller mindre resistenta mot penicillin. Cephalosporin C kan darfor anvandas for att skydda penicillin mot inaktivering genom sadana mikroorganismer. It has been mentioned above that cephalosporin C Or is unlikely for penicillinase, i.e. that it remains in 6— 192 926 - essentially unaffected by it. This is a very beneficial property of the new antibiotic, since it is equally valuable against such microorganisms as produce penicillinase and are therefore more or less resistant to penicillin. Cephalosporin C can therefore be used to protect penicillin against inactivation by such microorganisms.

Prov ha visat, att cephalosporin C forblir i huvudsak opaverkat av rent penicillinas alstrat av stammar av B. subtilis och B. cereus. Foljande tabell visor de mangder av olika penicillinaspreparat, som fordras fOr astadkommande av en 50- procentig inaktivering uttryckt i den mangd, som fordras fOr cephalosporin C, dividerad med den mangd, som fordras for samma mangd cephalosporin N. Tests have shown that cephalosporin C remains essentially unaffected by pure penicillinase generated by strains of B. subtilis and B. cereus. The following table shows the amounts of different penicillinase preparations required to achieve a 50% inactivation expressed in the amount required for cephalosporin C divided by the amount required for the same amount of cephalosporin N.

Tahell 1. Table 1.

Penieillinas Ursprung B. subtilis (slam 749) B. cereus (NRRL 569) B. cereus (NRRL 569) B. cereus 5/B De lagre, relativa mangder, vilka anges for de mindre rena penicillinaspreparaten, hero troligen pa narvaro av fororeningar med skadlig inverkan pa cephalosporin C. Origin of Penieillinas B. subtilis (sludge 749) B. cereus (NRRL 569) B. cereus (NRRL 569) B. cereus 5 / B adverse effects on cephalosporins C.

Cephalosporinets C verkan mot olika mikroorganismer framgar av foljande tabell, vilken emellertid icke far betraktas sasom angivande det fullstandiga bakteriologiska spektrumet och endast belyser den antibiotiska verkan, som liar kunnat faststallas hittills. The action of cephalosporin C against various microorganisms is shown in the following table, which, however, should not be construed as indicating the full bacteriological spectrum and only illustrates the antibiotic action which has hitherto been established.

Tabell 6. Table 6.

Organism LAgsta koneentration, som forhindrar tillvdxt under 24 h i pg/m1 Staph. aureus, Heatleystammen, penicillinkanslig 50-100 Staph. aureus, penicillinresistent Str. pyogenes B. anthracis N. meningilidis 1,6 N. gonorrhoeae 1,6 H. pertussis 1,6 H. influenzae 12, S. typhi S. paratyphi B. Organism Lowest concentration, which prevents growth for 24 hours in pg / m1 Staph. aureus, Heatley strain, penicillin probable 50-100 Staph. aureus, penicillin-resistant Str. pyogenes B. anthracis N. meningilidis 1.6 N. gonorrhoeae 1.6 H. pertussis 1.6 H. influenzae 12, S. typhi S. paratyphi B.

S. typhimurium V. cholerae Bad. friedlanderi Bact. coli 200 Cephalosporinets C egenskaper belysas genom bifogade ritningar, ddr fig. 1 utgor den ultra violetta absorptionskurvan och fig. 2 är det infraroda spektrumet. S. typhimurium V. cholerae Bad. friedlanderi Bact. coli 200 The properties of Cephalosporin C are illustrated by the accompanying drawings, where Fig. 1 is the ultraviolet absorption curve and Fig. 2 is the infrared spectrum.

Claims (10)

Patentansprak:Patent claim: 1. Satt att framstalla ett nytt, saval mot grampositiva som gramnegativa bakterier verksamt antibiotikum, kannetecknat ddrav, att ett naringssubstrat, som forjases med en art av Cephalosporium och som forutom det kanda antibiotiska amnet cephalosporin N innehaller annan, antibiotiskt verksam substans, eller lOsningar, som innehaller dessa antibiotiska substanser och som erhallits ur sadana forjasta naringssubstrat, behandlas for forstoring av cephalosporin N genom att naringssubstratet utsattes for inverkan av penicillinas eller ocksa. Mlles vid ett pH-varde av 2,5-5,5, varefter man fran naringssubstratet isolerar det nya antibiotiska amnet, som hdr benamnes cephalosporin C och som kan identifieras, dels darigenom att dess natriumsalt i vattenlos- ning liar en vridningsfOrmaga av [a]g =103°, dels darigenom att det ger en absorptionskurva for ultraviolett enligt fig. 1 och for infrarOtt enligt fig. 2 och dels darigenom att detsamma är okansligt for penicillinas, bildat av B. Subtilus.1. Introduced a new, saliva against gram-positive and gram-negative bacteria active antibiotic, can be drawn ddrav, that a nutrient substrate, which is fermented with a species of Cephalosporium and which in addition to the known antibiotic substance cephalosporin N contains another, antibiotic active substance, or solutions, which contain these antibiotic substances and which are obtained from such fermented nutrient substrates, are treated for enlargement of cephalosporin N by subjecting the nutrient substrate to the action of penicillinase or ox. Melt at a pH value of 2.5-5.5, after which the new antibiotic substance, which is called cephalosporin C and which can be identified, is isolated from the nutrient medium, partly because its sodium salt in aqueous solution gives a torsional capacity of [a ] g = 103 °, partly because it gives an absorption curve for ultraviolet according to Fig. 1 and for infrared according to Fig. 2 and partly because it is indistinguishable for penicillinase, formed by B. subtilus. 2. sat enligt patentanspraket 1, kannetecknat darav, att cephalosporin N fOrstores genom att naringssubstratet upphettas vid ett pH-varde av 2,5-5,0.2. according to claim 1, characterized in that the cephalosporin N is enlarged by heating the nutrient medium at a pH value of 2.5-5.0. 3. Satt enligt patentanspraket 1 eller 2, Munetecknat darav, att cephalosporin C isoleras frau det behandlade naringssubstratet genom losningsmedelsextraktion.3. A kit according to claim 1 or 2, characterized in that cephalosporin C is isolated from the treated nutrient medium by solvent extraction. 4. Satt enligt patentanspraket 1 eller 2, kannetecknat darav, att cephalosporin C isoleras Iran det behandlade naringssubstratet genom adsorption pa ett jonbytarmaterial och efterfoljande eluering ur delta med en vattenhaltig elueringslosning.4. A kit according to claim 1 or 2, characterized in that cephalosporin C is isolated from the treated nutrient substrate by adsorption on an ion exchange material and subsequent elution from the delta with an aqueous elution solution. 5. Satt enligt patentanspraket 4, kannetecknat darav, att elueringen genomfores med en vattenhaltig buffertlosning buffrad till ett pH av 2,58,0.5. A kit according to claim 4, characterized in that the elution is carried out with an aqueous buffer solution buffered to a pH of 2.58.0. 6. Satt enligt patentanspraket 5, kannetecknat darav, att buffertlosningen bildas genom neutralisering av en svag, tertiar bas.6. A kit according to claim 5, characterized in that the buffer solution is formed by neutralizing a weak, tertiary base. 7. Satt enligt patentanspraket 6, kannetecknat darav, att buffertlosningen framstalles genoni neutralisering av pyridin.7. A kit according to claim 6, characterized in that the buffer solution is prepared by neutralizing pyridine. 8. Satt enligt patentanspraket 4 eller 5, ka.nnetecknat darav, att cephalosporin C adsorberas pa ett konstharts.8. A kit according to claim 4 or 5, characterized in that cephalosporin C is adsorbed on a synthetic resin. 9. Satt enligt nagot av patentanspraken 4-8, kannetecknat darav, att den eluerade lOsningen av cephalosporin G behandlas med en jordalkalimetall for fanning ay syran ur buffertlosningen och bildning av jordalkalimetallsaltet av cephalosporin C, vilket omvandlas till natriumsaltet genom att losningen bringas i kontakt med ett katjonbytarmaterial i natriumformen. Renhet Relativ mangd C/N ra> 100 ra renad kristalliserad 10000 — —79. A kit according to any one of claims 4-8, characterized in that the eluted solution of cephalosporin G is treated with an alkaline earth metal to form the acid from the buffer solution and the formation of the alkaline earth metal salt of cephalosporin C, which is converted into the sodium salt by contacting the solution with a cation exchange material in the sodium form. Purity Relative amount C / N ra> 100 ra purified crystallized 10000 - —7 10. satt enligt nagot av patentanspraken 1-9, kannetecknat darav, att det forjasta naringssubstratet forst renas genom kontakt med aktivt kol, som elueras, varefter eluatet adsorberas pa aluminiumoxid, som sedan elueras till biklning av en renad losning innehallande de bagge typerna cephalosporin. Anforda publikationer: Chemical abstracts 46 (1952), sp. 10295. (Antibiotic production by species of cephalosporium). Nature 175 (1955), p. 548.10. according to any one of claims 1-9, characterized in that the fermented nutrient medium is first purified by contact with activated carbon, which is eluted, after which the eluate is adsorbed on alumina, which is then eluted to form a purified solution containing the ram types cephalosporins. Request publications: Chemical abstracts 46 (1952), sp. 10295. (Antibiotic production by species of cephalosporium). Nature 175 (1955), pp. 548.
SE192426D SE192426C1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE192426T

Publications (1)

Publication Number Publication Date
SE192426C1 true SE192426C1 (en) 1964-01-01

Family

ID=38411256

Family Applications (1)

Application Number Title Priority Date Filing Date
SE192426D SE192426C1 (en)

Country Status (1)

Country Link
SE (1) SE192426C1 (en)

Similar Documents

Publication Publication Date Title
US4174439A (en) Process for isolating glucopyranose compound from culture broths
US6013492A (en) Microbial process for producing calcium D-pantothenate
KR20080016826A (en) Method for purification of chlorinated sucrose derivatives by solvent extraction
DE3508372C2 (en) Process for the recovery of ceftazidime from an aqueous solution containing it
DE2604697A1 (en) ANTIBIOTICS
DE69628002T2 (en) PRODUCTION OF CLAVUNALATE SALTS
KR870001071B1 (en) Process for preparing highly crystalline sodium cefoperazone
NO119673B (en)
EP0640095B1 (en) Process for making vancomycin
US5258495A (en) Process for making vancomycin HC1
SE192426C1 (en)
US3733320A (en) Antibiotic purification processes
US5574135A (en) Process for making vancomycin
GB2441328A (en) A method for obtaining mupirocin calcium
US3093638A (en) Cephalosporin c
Chaiet et al. Phosphonomycin: Isolation from fermentation sources
EP0025233B1 (en) Method for purification of 6-(d-2-(d-2-amino-3-n-methylcarbamoylpropionamido)-2-p-hydroxyphenylacetamido)-penicillanic acid
US4048015A (en) Fortimicin C and process for production thereof
US2734014A (en) Glucoside colchicoside and a method of
SK69795A3 (en) Method of producing alpha, alpha-trehaloze
US3458572A (en) Tetracycline recovery process
EP0138708B1 (en) Isoefrotomycin
US2903457A (en) Isomer of cycloheximide and process
US3184454A (en) Recovery of cephalosporin c
RU2058316C1 (en) METHOD FOR PRODUCTION OF TOTAL α AND b ERGOCRYPTINES